| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.499 | 0.015 | 0.506 | Hypoglycemic | 0.493 0.016 DBMET01802 0.506 0.015 DBMET01803 0.506 0.015 DBMET01804 0.475 0.018 DBMET01805 0.475 0.018 DBMET01806 | DBMET01804 | |
| 0.471 | 0.081 | 0.471 | Beta lactamase inhibitor | |||
| 0.329 | 0.01 | 0.329 | Insulin secretagoues | 0.293 0.013 DBMET01802 0.326 0.01 DBMET01803 0.326 0.01 DBMET01804 0.305 0.012 DBMET01805 0.305 0.012 DBMET01806 | ||
| 0.367 | 0.063 | 0.367 | Thyroid hormone beta antagonist | 0.222 0.137 DBMET01803 0.222 0.137 DBMET01804 | ||
| 0.374 | 0.075 | 0.374 | Calpain 2 inhibitor | |||
| 0.3 | 0.003 | 0.3 | CC chemokine 3 receptor antagonist | 0.101 0.01 DBMET01802 0.149 0.006 DBMET01803 0.149 0.006 DBMET01804 0.119 0.008 DBMET01805 0.119 0.008 DBMET01806 | ||
| 0.316 | 0.021 | 0.316 | 5 Hydroxytryptamine 1E antagonist | 0.232 0.094 DBMET01802 0.225 0.102 DBMET01803 0.225 0.102 DBMET01804 0.201 0.129 DBMET01805 0.201 0.129 DBMET01806 | ||
| 0.272 | 0.003 | 0.272 | Potassium channel (ATP-sensitive) blocker | 0.169 0.004 DBMET01802 0.223 0.004 DBMET01803 0.223 0.004 DBMET01804 0.186 0.004 DBMET01805 0.186 0.004 DBMET01806 | ||
| 0.344 | 0.076 | 0.344 | Thyroid hormone antagonist | 0.21 0.154 DBMET01803 0.21 0.154 DBMET01804 | ||
| 0.288 | 0.024 | 0.29 | Diuretic | 0.209 0.041 DBMET01802 0.265 0.028 DBMET01803 0.265 0.028 DBMET01804 0.29 0.024 DBMET01805 0.29 0.024 DBMET01806 | DBMET01806 | |
| 0.298 | 0.057 | 0.361 | Cardiotonic | 0.361 0.036 DBMET01802 0.338 0.043 DBMET01803 0.338 0.043 DBMET01804 0.312 0.051 DBMET01805 0.312 0.051 DBMET01806 | DBMET01802 | |
| 0.231 | 0.004 | 0.231 | Carbonic anhydrase VII inhibitor | 0.091 0.01 DBMET01802 0.137 0.007 DBMET01803 0.137 0.007 DBMET01804 0.09 0.011 DBMET01805 0.09 0.011 DBMET01806 | ||
| 0.265 | 0.051 | 0.265 | Calpain inhibitor | |||
| 0.267 | 0.065 | 0.287 | Platelet antagonist | 0.287 0.057 DBMET01802 0.287 0.057 DBMET01803 0.287 0.057 DBMET01804 0.278 0.061 DBMET01805 0.278 0.061 DBMET01806 | DBMET01804 | |
| 0.226 | 0.024 | 0.226 | Sodium channel blocker | 0.12 0.084 DBMET01803 0.12 0.084 DBMET01804 0.112 0.095 DBMET01805 0.112 0.095 DBMET01806 | ||
| 0.332 | 0.136 | 0.414 | Cyclophilin D inhibitor | 0.384 0.1 DBMET01802 0.414 0.083 DBMET01803 0.414 0.083 DBMET01804 0.393 0.095 DBMET01805 0.393 0.095 DBMET01806 | DBMET01804 | |
| 0.181 | 0.005 | 0.181 | Glycine transporter inhibitor | 0.048 0.033 DBMET01802 0.061 0.024 DBMET01803 0.061 0.024 DBMET01804 0.052 0.03 DBMET01805 0.052 0.03 DBMET01806 | ||
| 0.194 | 0.019 | 0.194 | Chemokine receptor antagonist | 0.108 0.056 DBMET01802 0.13 0.041 DBMET01803 0.13 0.041 DBMET01804 0.124 0.045 DBMET01805 0.124 0.045 DBMET01806 | ||
| 0.167 | 0.013 | 0.17 | Carbonic anhydrase inhibitor | 0.106 0.025 DBMET01802 0.17 0.013 DBMET01803 0.17 0.013 DBMET01804 0.119 0.022 DBMET01805 0.119 0.022 DBMET01806 | DBMET01804 | |
| 0.154 | 0.009 | 0.154 | Carbonic anhydrase I inhibitor | 0.089 0.021 DBMET01802 0.151 0.01 DBMET01803 0.151 0.01 DBMET01804 0.11 0.016 DBMET01805 0.11 0.016 DBMET01806 | ||
| 0.157 | 0.013 | 0.157 | Cannabinoid receptor antagonist | 0.079 0.041 DBMET01802 0.068 0.052 DBMET01805 0.068 0.052 DBMET01806 | ||
| 0.152 | 0.012 | 0.152 | Carbonic anhydrase IX inhibitor | 0.068 0.033 DBMET01802 0.09 0.023 DBMET01803 0.09 0.023 DBMET01804 0.061 0.037 DBMET01805 0.061 0.037 DBMET01806 | ||
| 0.15 | 0.014 | 0.15 | Carbonic anhydrase V inhibitor | 0.081 0.035 DBMET01802 0.095 0.029 DBMET01803 0.095 0.029 DBMET01804 0.068 0.044 DBMET01805 0.068 0.044 DBMET01806 | ||
| 0.147 | 0.012 | 0.147 | Epoxide hydrolase inhibitor | 0.078 0.044 DBMET01802 0.11 0.02 DBMET01803 0.11 0.02 DBMET01804 0.126 0.016 DBMET01805 0.126 0.016 DBMET01806 | ||
| 0.134 | 0.005 | 0.134 | Carbonic anhydrase XIV inhibitor | 0.094 0.012 DBMET01802 0.117 0.007 DBMET01803 0.117 0.007 DBMET01804 0.097 0.012 DBMET01805 0.097 0.012 DBMET01806 | ||
| 0.213 | 0.085 | 0.213 | Potassium channel blocker | 0.201 0.092 DBMET01802 0.143 0.142 DBMET01803 0.143 0.142 DBMET01804 0.146 0.139 DBMET01805 0.146 0.139 DBMET01806 | ||
| 0.139 | 0.018 | 0.143 | Adrenaline agonist | 0.139 0.018 DBMET01802 0.143 0.017 DBMET01803 0.143 0.017 DBMET01804 0.117 0.027 DBMET01805 0.117 0.027 DBMET01806 | DBMET01804 | |
| 0.127 | 0.006 | 0.129 | Thromboxane antagonist | 0.129 0.006 DBMET01802 0.118 0.007 DBMET01803 0.118 0.007 DBMET01804 0.107 0.009 DBMET01805 0.107 0.009 DBMET01806 | DBMET01802 | |
| 0.135 | 0.014 | 0.135 | Carbonic anhydrase XII inhibitor | 0.048 0.04 DBMET01802 0.073 0.028 DBMET01803 0.073 0.028 DBMET01804 | ||
| 0.126 | 0.005 | 0.126 | Bombesin 3 receptor antagonist | 0.106 0.01 DBMET01802 0.106 0.01 DBMET01803 0.106 0.01 DBMET01804 0.103 0.011 DBMET01805 0.103 0.011 DBMET01806 | ||
| 0.247 | 0.128 | 0.308 | Antithrombotic | 0.308 0.083 DBMET01802 0.308 0.083 DBMET01803 0.308 0.083 DBMET01804 0.274 0.108 DBMET01805 0.274 0.108 DBMET01806 | DBMET01804 | |
| 0.163 | 0.047 | 0.163 | Neuropeptide Y1 antagonist | |||
| 0.13 | 0.013 | 0.135 | Carbonic anhydrase II inhibitor | 0.086 0.023 DBMET01802 0.135 0.012 DBMET01803 0.135 0.012 DBMET01804 0.096 0.02 DBMET01805 0.096 0.02 DBMET01806 | DBMET01804 | |
| 0.131 | 0.015 | 0.131 | Carbonic anhydrase VA inhibitor | 0.08 0.036 DBMET01802 0.09 0.03 DBMET01803 0.09 0.03 DBMET01804 0.071 0.045 DBMET01805 0.071 0.045 DBMET01806 | ||
| 0.138 | 0.022 | 0.138 | Metalloproteinase-2 inhibitor | 0.122 0.028 DBMET01802 0.105 0.036 DBMET01803 0.105 0.036 DBMET01804 0.085 0.048 DBMET01805 0.085 0.048 DBMET01806 | ||
| 0.125 | 0.011 | 0.125 | Prostaglandin E2 antagonist | 0.081 0.019 DBMET01802 0.097 0.015 DBMET01803 0.097 0.015 DBMET01804 0.082 0.019 DBMET01805 0.082 0.019 DBMET01806 | ||
| 0.115 | 0.005 | 0.115 | Potassium channel (Inward rectifier) blocker | 0.08 0.013 DBMET01802 0.097 0.008 DBMET01803 0.097 0.008 DBMET01804 0.093 0.008 DBMET01805 0.093 0.008 DBMET01806 | ||
| 0.139 | 0.033 | 0.139 | Sphingosine 1-phosphate receptor 2 agonist | 0.13 0.041 DBMET01802 0.133 0.038 DBMET01803 0.133 0.038 DBMET01804 0.126 0.047 DBMET01805 0.126 0.047 DBMET01806 | ||
| 0.114 | 0.012 | 0.114 | Bcl2 antagonist | 0.095 0.021 DBMET01802 0.103 0.016 DBMET01803 0.103 0.016 DBMET01804 0.096 0.02 DBMET01805 0.096 0.02 DBMET01806 | ||
| 0.149 | 0.048 | 0.149 | Nav1.3 sodium channel blocker | |||
| 0.113 | 0.015 | 0.149 | Potassium channel Kv1.5 blocker | 0.149 0.008 DBMET01802 0.106 0.017 DBMET01803 0.106 0.017 DBMET01804 0.095 0.02 DBMET01805 0.095 0.02 DBMET01806 | DBMET01802 | |
| 0.206 | 0.108 | 0.206 | Neuropeptide Y2 antagonist | |||
| 0.103 | 0.007 | 0.105 | Thromboxane A2 antagonist | 0.105 0.006 DBMET01802 0.098 0.008 DBMET01803 0.098 0.008 DBMET01804 0.09 0.01 DBMET01805 0.09 0.01 DBMET01806 | DBMET01802 | |
| 0.121 | 0.026 | 0.121 | CC chemokine receptor antagonist | 0.085 0.047 DBMET01803 0.085 0.047 DBMET01804 0.081 0.051 DBMET01805 0.081 0.051 DBMET01806 | ||
| 0.112 | 0.027 | 0.112 | Metalloproteinase-9 inhibitor | 0.103 0.031 DBMET01802 0.086 0.04 DBMET01803 0.086 0.04 DBMET01804 0.07 0.056 DBMET01805 0.07 0.056 DBMET01806 | ||
| 0.088 | 0.005 | 0.088 | Potassium channel Kv1.1 blocker | 0.037 0.029 DBMET01802 0.044 0.018 DBMET01803 0.044 0.018 DBMET01804 0.037 0.028 DBMET01805 0.037 0.028 DBMET01806 | ||
| 0.114 | 0.032 | 0.114 | Carbonic anhydrase XIII inhibitor | 0.085 0.047 DBMET01802 0.088 0.044 DBMET01803 0.088 0.044 DBMET01804 0.068 0.06 DBMET01805 0.068 0.06 DBMET01806 | ||
| 0.114 | 0.032 | 0.114 | Neuropeptide Y antagonist | |||
| 0.09 | 0.013 | 0.09 | Beta 1 adrenoreceptor antagonist | 0.086 0.014 DBMET01802 0.083 0.016 DBMET01803 0.083 0.016 DBMET01804 0.073 0.023 DBMET01805 0.073 0.023 DBMET01806 | ||
| 0.095 | 0.018 | 0.095 | Cannabinoid CB1 receptor antagonist | 0.056 0.049 DBMET01802 | ||
| 0.093 | 0.017 | 0.093 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 DBMET01802 0.081 0.023 DBMET01803 0.081 0.023 DBMET01804 0.069 0.035 DBMET01805 0.069 0.035 DBMET01806 | ||
| 0.1 | 0.024 | 0.1 | CXC chemokine receptor antagonist | 0.065 0.057 DBMET01803 0.065 0.057 DBMET01804 | ||
| 0.081 | 0.007 | 0.081 | Carbonic anhydrase I stimulant | 0.062 0.011 DBMET01802 0.064 0.011 DBMET01803 0.064 0.011 DBMET01804 0.059 0.012 DBMET01805 0.059 0.012 DBMET01806 | ||
| 0.082 | 0.007 | 0.082 | Potassium channel (Inward rectifier) activator | 0.064 0.016 DBMET01802 0.069 0.012 DBMET01803 0.069 0.012 DBMET01804 0.063 0.016 DBMET01805 0.063 0.016 DBMET01806 | ||
| 0.076 | 0.005 | 0.095 | Prostaglandin EP4 antagonist | 0.06 0.007 DBMET01802 0.095 0.005 DBMET01803 0.095 0.005 DBMET01804 0.067 0.006 DBMET01805 0.067 0.006 DBMET01806 | DBMET01804 | |
| 0.078 | 0.01 | 0.078 | Carbonic anhydrase II stimulant | 0.065 0.018 DBMET01802 0.066 0.017 DBMET01803 0.066 0.017 DBMET01804 0.064 0.019 DBMET01805 0.064 0.019 DBMET01806 | ||
| 0.076 | 0.008 | 0.076 | Potassium channel (ATP-sensitive) activator | 0.059 0.017 DBMET01802 0.064 0.013 DBMET01803 0.064 0.013 DBMET01804 0.058 0.018 DBMET01805 0.058 0.018 DBMET01806 | ||
| 0.092 | 0.025 | 0.092 | Neutrophil collagenase inhibitor | 0.07 0.039 DBMET01802 0.063 0.047 DBMET01803 0.063 0.047 DBMET01804 | ||
| 0.153 | 0.088 | 0.157 | Cyclin-dependent kinase 3 inhibitor | 0.157 0.081 DBMET01802 0.139 0.125 DBMET01803 0.139 0.125 DBMET01804 | DBMET01802 | |
| 0.07 | 0.005 | 0.079 | CC chemokine 1 receptor antagonist | 0.027 0.014 DBMET01802 0.068 0.005 DBMET01803 0.068 0.005 DBMET01804 0.079 0.005 DBMET01805 0.079 0.005 DBMET01806 | DBMET01806 | |
| 0.076 | 0.013 | 0.114 | Potassium channel Kv1.3 blocker | 0.063 0.019 DBMET01802 0.114 0.006 DBMET01803 0.114 0.006 DBMET01804 0.081 0.012 DBMET01805 0.081 0.012 DBMET01806 | DBMET01804 | |
| 0.092 | 0.03 | 0.092 | Matrix metalloproteinase inhibitor | 0.076 0.039 DBMET01802 0.075 0.04 DBMET01803 0.075 0.04 DBMET01804 0.062 0.052 DBMET01805 0.062 0.052 DBMET01806 | ||
| 0.083 | 0.025 | 0.098 | Beta adrenoreceptor antagonist | 0.098 0.017 DBMET01802 0.088 0.022 DBMET01803 0.088 0.022 DBMET01804 0.075 0.032 DBMET01805 0.075 0.032 DBMET01806 | DBMET01802 | |
| 0.131 | 0.072 | 0.131 | Sodium channel (voltage-gated) blocker | |||
| 0.098 | 0.04 | 0.139 | Carbonic anhydrase VI inhibitor | 0.139 0.023 DBMET01802 0.102 0.038 DBMET01803 0.102 0.038 DBMET01804 0.086 0.051 DBMET01805 0.086 0.051 DBMET01806 | DBMET01802 | |
| 0.079 | 0.023 | 0.079 | Prostaglandin antagonist | 0.048 0.041 DBMET01802 0.058 0.033 DBMET01803 0.058 0.033 DBMET01804 0.049 0.041 DBMET01805 0.049 0.041 DBMET01806 | ||
| 0.076 | 0.023 | 0.076 | Matrix metalloproteinase 1 inhibitor | 0.069 0.026 DBMET01802 0.066 0.028 DBMET01803 0.066 0.028 DBMET01804 0.055 0.035 DBMET01805 0.055 0.035 DBMET01806 | ||
| 0.07 | 0.017 | 0.074 | Beta 2 adrenoreceptor antagonist | 0.074 0.014 DBMET01802 0.071 0.016 DBMET01803 0.071 0.016 DBMET01804 0.062 0.022 DBMET01805 0.062 0.022 DBMET01806 | DBMET01802 | |
| 0.071 | 0.019 | 0.071 | Bcl-xL inhibitor | 0.063 0.032 DBMET01802 0.065 0.028 DBMET01803 0.065 0.028 DBMET01804 0.062 0.034 DBMET01805 0.062 0.034 DBMET01806 | ||
| 0.056 | 0.004 | 0.056 | Beta 1 adrenoreceptor agonist | 0.039 0.005 DBMET01802 0.056 0.004 DBMET01803 0.056 0.004 DBMET01804 0.044 0.004 DBMET01805 0.044 0.004 DBMET01806 | ||
| 0.068 | 0.023 | 0.073 | Beta 2 adrenoreceptor agonist | 0.073 0.015 DBMET01802 0.072 0.016 DBMET01803 0.072 0.016 DBMET01804 0.067 0.025 DBMET01805 0.067 0.025 DBMET01806 | DBMET01802 | |
| 0.15 | 0.106 | 0.174 | Platelet adhesion inhibitor | 0.151 0.105 DBMET01802 0.174 0.086 DBMET01803 0.174 0.086 DBMET01804 0.153 0.103 DBMET01805 0.153 0.103 DBMET01806 | DBMET01804 | |
| 0.065 | 0.022 | 0.065 | Epithelial sodium channel blocker | |||
| 0.054 | 0.012 | 0.057 | Beta adrenoreceptor agonist | 0.056 0.01 DBMET01802 0.057 0.01 DBMET01803 0.057 0.01 DBMET01804 0.051 0.016 DBMET01805 0.051 0.016 DBMET01806 | DBMET01804 | |
| 0.066 | 0.026 | 0.066 | Cannabinoid CB2 receptor antagonist | |||
| 0.081 | 0.041 | 0.081 | Thrombin inhibitor | 0.068 0.058 DBMET01802 0.069 0.057 DBMET01803 0.069 0.057 DBMET01804 0.065 0.063 DBMET01805 0.065 0.063 DBMET01806 | ||
| 0.134 | 0.095 | 0.134 | Anticoagulant | 0.125 0.105 DBMET01803 0.125 0.105 DBMET01804 0.118 0.114 DBMET01805 0.118 0.114 DBMET01806 | ||
| 0.056 | 0.02 | 0.056 | Collagenase inhibitor | 0.051 0.031 DBMET01802 0.052 0.028 DBMET01803 0.052 0.028 DBMET01804 0.051 0.031 DBMET01805 0.051 0.031 DBMET01806 | ||
| 0.043 | 0.008 | 0.043 | Epoxide hydrolase 2 inhibitor | 0.025 0.017 DBMET01802 0.034 0.012 DBMET01803 0.034 0.012 DBMET01804 0.033 0.012 DBMET01805 0.033 0.012 DBMET01806 | ||
| 0.125 | 0.092 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.092 DBMET01802 0.124 0.095 DBMET01803 0.124 0.095 DBMET01804 0.123 0.102 DBMET01805 0.123 0.102 DBMET01806 | ||
| 0.046 | 0.014 | 0.046 | Integrin alpha2 antagonist | 0.034 0.033 DBMET01802 0.035 0.028 DBMET01803 0.035 0.028 DBMET01804 | ||
| 0.058 | 0.03 | 0.058 | Thromboxane synthase inhibitor | |||
| 0.189 | 0.164 | 0.189 | 12-Lipoxygenase inhibitor | |||
| 0.103 | 0.079 | 0.103 | Nav1.5 sodium channel blocker | |||
| 0.192 | 0.169 | 0.192 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.04 | 0.02 | 0.04 | Glycine transporter 1 inhibitor | |||
| 0.073 | 0.055 | 0.073 | Vanilloid 4 agonist | |||
| 0.051 | 0.032 | 0.051 | Metalloproteinase-3 inhibitor | |||
| 0.215 | 0.197 | 0.215 | 15-Lipoxygenase inhibitor | |||
| 0.091 | 0.073 | 0.091 | Electrolyte absorption antagonist | |||
| 0.091 | 0.074 | 0.135 | Bronchodilator | 0.135 0.037 DBMET01802 0.129 0.04 DBMET01803 0.129 0.04 DBMET01804 0.121 0.044 DBMET01805 0.121 0.044 DBMET01806 | DBMET01802 | |
| 0.061 | 0.045 | 0.061 | Trypsin inhibitor | 0.058 0.054 DBMET01802 0.057 0.055 DBMET01803 0.057 0.055 DBMET01804 | ||
| 0.112 | 0.097 | 0.112 | Alkaline phosphatase inhibitor | |||
| 0.018 | 0.005 | 0.018 | Beta 3 adrenoreceptor agonist | 0.014 0.006 DBMET01803 0.014 0.006 DBMET01804 | ||
| 0.092 | 0.079 | 0.092 | Carbonic anhydrase XV inhibitor | |||
| 0.038 | 0.03 | 0.038 | Aggrecanase 1 inhibitor | |||
| 0.027 | 0.021 | 0.027 | Melatonin antagonist | |||
| 0.04 | 0.033 | 0.05 | Carbonic anhydrase IV inhibitor | 0.05 0.025 DBMET01803 0.05 0.025 DBMET01804 | DBMET01804 | |
| 0.03 | 0.023 | 0.03 | Cyclophilin A inhibitor | 0.029 0.024 DBMET01803 0.029 0.024 DBMET01804 0.028 0.027 DBMET01805 0.028 0.027 DBMET01806 | ||
| 0.055 | 0.049 | 0.055 | Collagenase 3 inhibitor | |||
| 0.016 | 0.01 | 0.016 | Carbonic anhydrase IV stimulant | |||
| 0.22 | 0.214 | 0.306 | Analgesic | 0.306 0.137 DBMET01802 0.24 0.192 DBMET01805 0.24 0.192 DBMET01806 | DBMET01802 | |
| 0.025 | 0.02 | 0.025 | Calcium-sensing receptor agonist | |||
| 0.035 | 0.029 | 0.035 | Bradykinin antagonist | |||
| 0.041 | 0.036 | 0.041 | Factor Xa inhibitor | |||
| 0.052 | 0.049 | 0.06 | Prostaglandin EP2 antagonist | 0.052 0.049 DBMET01802 0.06 0.041 DBMET01803 0.06 0.041 DBMET01804 0.054 0.047 DBMET01805 0.054 0.047 DBMET01806 | DBMET01804 | |
| 0.047 | 0.045 | 0.047 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.052 | 0.051 | 0.052 | Carbonic anhydrase stimulant | |||
| 0.025 | 0.023 | 0.025 | Bradykinin B1 receptor antagonist | |||
| 0.055 | 0.055 | 0.068 | Prostaglandin F2 alpha antagonist | 0.067 0.035 DBMET01802 0.068 0.035 DBMET01803 0.068 0.035 DBMET01804 0.064 0.04 DBMET01805 0.064 0.04 DBMET01806 | DBMET01804 | |
| 0.255 | 0.261 | 0.379 | Antiinflammatory | 0.379 0.152 DBMET01802 0.374 0.156 DBMET01803 0.374 0.156 DBMET01804 0.357 0.167 DBMET01805 0.357 0.167 DBMET01806 | DBMET01802 | |
| 0.077 | 0.082 | 0.086 | Potassium channel activator | 0.086 0.066 DBMET01802 | DBMET01802 | |
| 0.138 | 0.148 | 0.151 | Potassium channel (Voltage-sensitive) blocker | 0.151 0.136 DBMET01802 | DBMET01802 | |
| 0.133 | 0.144 | 0.167 | Non-steroidal antiinflammatory agent | 0.142 0.127 DBMET01802 0.167 0.098 DBMET01803 0.167 0.098 DBMET01804 0.139 0.132 DBMET01805 0.139 0.132 DBMET01806 | DBMET01804 | |
| 0.032 | 0.043 | 0.042 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.033 DBMET01802 0.042 0.018 DBMET01803 0.042 0.018 DBMET01804 0.041 0.02 DBMET01805 0.041 0.02 DBMET01806 | DBMET01804 | |
| 0.017 | 0.028 | 0.022 | CYP24 inhibitor | 0.022 0.017 DBMET01803 0.022 0.017 DBMET01804 0.021 0.018 DBMET01805 0.021 0.018 DBMET01806 | DBMET01804 | |
| 0.074 | 0.097 | 0.078 | T cell inhibitor | 0.078 0.075 DBMET01803 0.078 0.075 DBMET01804 | DBMET01804 | |
| 0.189 | 0.215 | 0.275 | Toll-Like receptor 7 agonist | 0.226 0.171 DBMET01802 0.25 0.148 DBMET01803 0.25 0.148 DBMET01804 0.275 0.127 DBMET01805 0.275 0.127 DBMET01806 | DBMET01806 | |
| 0.019 | 0.064 | 0.057 | Farnesoid X receptor agonist | 0.049 0.015 DBMET01803 0.049 0.015 DBMET01804 0.057 0.011 DBMET01805 0.057 0.011 DBMET01806 | DBMET01806 | |
| 0.181 | 0.227 | 0.266 | Toll-Like receptor agonist | 0.218 0.181 DBMET01802 0.241 0.156 DBMET01803 0.241 0.156 DBMET01804 0.266 0.134 DBMET01805 0.266 0.134 DBMET01806 | DBMET01806 | |
| 0.184 | 0.234 | 0.292 | Alpha-glucosidase inhibitor | 0.292 0.164 DBMET01802 | DBMET01802 | |
| 0.067 | 0.128 | 0.087 | Vanilloid agonist | 0.087 0.052 DBMET01802 0.083 0.062 DBMET01805 0.083 0.062 DBMET01806 | DBMET01802 | |
| 0.201 | 0.267 | 0.288 | MAP kinase kinase 6 inhibitor | 0.288 0.147 DBMET01802 | DBMET01802 | |
| 0.064 | 0.159 | 0.117 | AMP-activated protein kinase stimulant | 0.117 0.051 DBMET01803 0.117 0.051 DBMET01804 0.093 0.081 DBMET01805 0.093 0.081 DBMET01806 | DBMET01804 | |
| 0.015 | 0.132 | 0.039 | Phosphorylase inhibitor | 0.039 0.038 DBMET01802 | DBMET01802 | |
| 0.08 | 0.215 | 0.123 | Farnesoid X receptor antagonist | 0.123 0.098 DBMET01803 0.123 0.098 DBMET01804 0.118 0.109 DBMET01805 0.118 0.109 DBMET01806 | DBMET01804 | |
| 0.101 | 0.238 | 0.153 | ATPase inhibitor | 0.153 0.096 DBMET01803 0.153 0.096 DBMET01804 | DBMET01804 | |
| 0.041 | 0.186 | 0.081 | MAP kinase kinase 8 inhibitor | 0.081 0.034 DBMET01805 0.081 0.034 DBMET01806 | DBMET01806 | |
| 0.017 | 0.22 | 0.037 | Antibiotic Aminoglycoside-like | 0.037 0.024 DBMET01802 0.033 0.031 DBMET01805 0.033 0.031 DBMET01806 | DBMET01802 | |
| 0.117 | 0.324 | 0.199 | Peptidyltransferase inhibitor | 0.173 0.141 DBMET01802 0.199 0.1 DBMET01803 0.199 0.1 DBMET01804 0.187 0.117 DBMET01805 0.187 0.117 DBMET01806 | DBMET01804 | |
| 0.07 | 0.283 | 0.145 | Hypolipemic | 0.145 0.143 DBMET01803 0.145 0.143 DBMET01804 0.145 0.142 DBMET01805 0.145 0.142 DBMET01806 | DBMET01806 | |
| 0.072 | 0.301 | 0.122 | Adenylate cyclase stimulant | 0.122 0.119 DBMET01802 | DBMET01802 | |
| 0.082 | 0.324 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 DBMET01803 0.137 0.136 DBMET01804 | DBMET01804 | |
| 0.086 | 0.336 | 0.195 | Transcription factor NF kappa B inhibitor | 0.195 0.174 DBMET01803 0.195 0.174 DBMET01804 | DBMET01804 | |
| 0.104 | 0.376 | 0.265 | Sodium/bile acid cotransporter inhibitor | 0.213 0.171 DBMET01802 0.265 0.113 DBMET01803 0.265 0.113 DBMET01804 0.25 0.128 DBMET01805 0.25 0.128 DBMET01806 | DBMET01804 | |
| 0.004 | 0.541 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET01805 0.027 0.025 DBMET01806 | DBMET01806 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |